MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-05-2025
LivaNova PLC Book Value 2011-2025 | LIVN
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value LivaNova PLC
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.32 B | 1.28 B | 1.21 B | 1.29 B | 1.12 B | 1.38 B | 1.5 B | 1.82 B | 1.71 B | 277 M | 259 M | 230 M | 183 M | 175 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.82 B | 175 M | 982 M |
Quarterly Book Value LivaNova PLC
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.16 B | 1.12 B | 1.03 B | 1.32 B | - | 1.24 B | 1.22 B | 1.28 B | 1.23 B | 1.24 B | 1.23 B | 1.21 B | 1.15 B | - | 1.29 B | 1.29 B | 1.31 B | 1.04 B | 1.07 B | 1.11 B | 1.12 B | 1.33 B | 1.12 B | 1.38 B | 1.38 B | 1.38 B | 1.38 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.82 B | 1.82 B | 1.82 B | 1.82 B | 1.71 B | 1.71 B | 1.71 B | 1.71 B | 1.81 B | 1.81 B | 1.81 B | 1.81 B | - | - | - | 259 M | - | - | - | 264 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.82 B | 259 M | 1.36 B |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
1.33 B | - | - | $ 17.2 B |  USA |
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Boston Scientific Corporation
BSX
|
39.4 B | $ 96.13 | 0.04 % | $ 141 B | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M |  China |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
Apyx Medical Corporation
APYX
|
26.9 M | $ 3.6 | - | $ 125 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | USA |
 |
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | USA |
 |
Bio-Rad Laboratories
BIO
|
6.57 B | $ 301.75 | 0.24 % | $ 8.51 B | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
BioSig Technologies
BSGM
|
-1.42 M | - | 37.08 % | $ 85.7 M | USA |
 |
Bruker Corporation
BRKR
|
1.82 B | $ 48.12 | 0.21 % | $ 7.17 K | USA |
 |
Abbott Laboratories
ABT
|
81.4 B | $ 124.81 | 0.22 % | $ 217 B | USA |
 |
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | $ 2.97 | 4.58 % | $ 111 M |  France |
 |
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | USA |
 |
InMode Ltd.
INMD
|
704 M | $ 14.47 | 0.7 % | $ 1.15 B |  Israel |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B | Israel |
 |
IRIDEX Corporation
IRIX
|
9.52 M | $ 1.14 | 3.64 % | $ 18.4 M | USA |
 |
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
IRadimed Corporation
IRMD
|
86.8 M | $ 97.06 | 0.48 % | $ 1.23 B | USA |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | USA |
 |
LENSAR
LNSR
|
18.6 M | $ 12.01 | -0.08 % | $ 138 M | USA |
 |
Medigus Ltd.
MDGS
|
17.6 M | - | 10.28 % | $ 55.5 M | Israel |
|
Cognyte Software Ltd.
CGNT
|
217 M | $ 9.54 | - | $ 685 M | Israel |
 |
Second Sight Medical Products
EYES
|
17.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
3.85 B | $ 157.84 | 0.69 % | $ 11.8 B | USA |
 |
NanoVibronix
NAOV
|
627 K | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
81.2 M | $ 0.86 | 0.43 % | $ 88.4 M | USA |
 |
Myomo
MYO
|
6.36 M | $ 1.02 | 12.09 % | $ 7.19 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
25.4 M | $ 14.49 | 0.84 % | $ 392 M | USA |
 |
FONAR Corporation
FONR
|
146 M | $ 14.53 | 0.07 % | $ 95.2 M | USA |
 |
AxoGen
AXGN
|
104 M | $ 32.64 | -0.61 % | $ 1.44 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
2.81 M | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
963 M | $ 40.17 | 1.34 % | $ 1.24 B | USA |
 |
NuVasive
NUVA
|
2.22 B | - | - | $ 2.07 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
355 M | $ 17.41 | 0.75 % | $ 402 M | USA |
 |
Globus Medical
GMED
|
4.18 B | $ 88.43 | -0.38 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
1.55 B | $ 12.66 | 0.56 % | $ 975 M | USA |